Churg-Strauss syndrome: Outcome and long-term follow-up of 38 patients from a single Italian centre;Caratteristiche clinico-sierologiche e dati di outcome di una casistica monocentrica di pazienti affetti da sindrome di Churg-Strauss

Reumatismo

Volumn 61, Issue 2, 2009, Pages 118-124

  Baldini, Chiara ^a   Della Rossa, A ^a   Grossi, S ^a   Catarsi, E ^a   Talarico, R ^a   d'Ascanio, A ^a   Mosca, M ^a   Neri, R ^a   Tavoni, A ^a   Bombardieri, S ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

ANCA associated vasculitis; Antineutrophil cytoplasmic antibodies; Churg Strauss Syndrome; Damage; Disease activity

Indexed keywords

MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADULT; AGED; ANTIBODY DETECTION; ARTICLE; ASTHMA; CATARACT; CHURG STRAUSS SYNDROME; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FOLLOW UP; FRACTURE; GASTROINTESTINAL DISEASE; HEART DISEASE; HUMAN; ITALY; KIDNEY DISEASE; LUNG DISEASE; MALE; NEUROLOGIC DISEASE; OUTCOME ASSESSMENT; PATIENT MONITORING; PERIPHERAL NEUROPATHY; PREDICTION; PROGNOSIS; RELAPSE; RETROSPECTIVE STUDY; SEROLOGY; SKIN DISEASE;

ADULT; AGED; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; BIOLOGICAL MARKERS; CHI-SQUARE DISTRIBUTION; CHURG-STRAUSS SYNDROME; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUNG DISEASES; MALE; MIDDLE AGED; PERIPHERAL NERVOUS SYSTEM DISEASES; PREDICTIVE VALUE OF TESTS; RECURRENCE; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 68149159179     PISSN: 00487449     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Pagnoux C, Guilpain P, Guillevin L. Churg-Strauss syndrome. Curr Opin Rheumatol 2007; 19: 25-32.
2. Grau RG. Churg-Strauss syndrome: 2005-2008 update. Curr Rheumatol Rep 2008; 10: 453-8.
3. Hellmich B, Ehlers S, Csernok E, Gross WL. Update on the pathogenesis of Churg-Strauss syndrome. Clin Exp Rheumatol 2003; 21 (6 Suppl 32): S69-77.
4. Savige J, Gillis D, Benson E, Davies D, Esnault V, Falk RJ, et al. International Consensus Statement on Testing and Reporting of Antineutrophil Cytoplasmic Antibodies (ANCA). Am J Clin Pathol 1999; 111: 507-13.
5. Sablé-Fourtassou R, Cohen P, Mahr A, Pagnoux C, Mouthon L, Jayne D, et al, French Vasculitis Study Group. Antineutrophil cytoplasmic antibodies and the Churg-Strauss syndrome. Ann Intern Med 2005; 143: 632-8.
6. Sinico RA, Di Toma L, Maggiore U, Bottero P, Radice A, Tosoni C, et al. Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome. Arthritis Rheum 2005; 52: 2926-35.
7. Kallenberg CG. Churg-Strauss syndrome: just one disease entity? Arthritis Rheum 2005; 52: 2589-93.
8. Metzler C, Schnabel A, Gross WL, Hellmich B. A phase II study of interferon-alpha for the treatment of refractory Churg-Strauss syndrome. Clin Exp Rheumatol 2008; 26 (3 Suppl 49): S35-40.
9. Luqmani RA, Robinson H. Introduction to, and classification of, the systemic vasculitides. Best Pract Res Clin Rheumatol 2001; 15: 187-202.
10. Jennette JC, Falk RJ. The role of pathology in the diagnosis of systemic vasculitis. Clin Exp Rheumatol 2007; 25 (1 Suppl 44): S52-6.
11. Mukhtyar C, Luqmani R. Disease-specific quality indicators, guidelines, and outcome measures in vasculitis. Clin Exp Rheumatol 2007; 25 (6 Suppl 47): 120-9.
12. Mahr AD, Neogi T, Lavalley MP, Davis JC, Hoffman GS, McCune WJ, et al, Wegener's Granulomatosis Etanercept Trial Research Group. Assessment of the item selection and weighting in the Birmingham vasculitis activity score for Wegener's granulomatosis. Arthritis Rheum 2008; 59: 884-91.
13. Luqmani RA, Bacon PA, Moots RJ, Janssen BA, Pall A, Emery P, Savage C, Adu D. Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. QJM 1994; 87: 671-8.
14. Exley AR, Bacon PA, Luqmani RA, Kitas GD, Gordon C, Savage CO, Adu D. Development and initial validation of the vasculitis damage index for the standardized clinical assessment of damage in the systemic vasculitides. Arthritis Rheum 1997; 40: 371-80.
15. Lanham JG, Elkon KB, Pusey CD, Hughes GR. Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome. Medicine 1984; 63: 65-81.
16. Solans R, Bosch JA, Perez-Bocanegra C et al. Churg-Strauss syndrome: outcome and long-term follow-up of 32 patients. Rheumatology 2001; 40: 763-71.
17. Chumbley LC, Harrison EG Jr, DeRemee RA. Allergic granulomatosis and angiitis (Churg-Strauss syndrome). Report and analysis of 30 cases. Mayo Clin Proc 1994; 52: 477-84.
18. Gaskin G, Clutterbuck EJ, Pusey CD. Renal disease in the Churg-Strauss syndrome. Diagnosis management and outcome. Contrib Nephrol 1991; 94: 58-65.
19. Abu-Shakra M, Smythe H, Lewtas J, Badley E, Weber D, Keystone E. Outcome of polyarteritis nodosa and Churg-Strauss syndrome. An analysis of twenty-five patients. Arthritis Rheum 1994; 37: 1798-803.
20. Guillevin L, Cohen P, Gayraud M, Lhote F, Jarrousse B, Casassus P. Churg-Strauss syndrome: clinical study and long term follow-up of 96 patients. Medicine 1999; 78: 26-37.
21. Merkel PA. Part 1: The need for novel treatment regimens for ANCA-associated vasculitis. Clin Exp Rheumatol 2007; 25 (1 Suppl 44): S72-3.
22. Phillip R, Luqmani R. Mortality in systemic vasculitis: a systematic review. Clin Exp Rheumatol 2008; 26 (5 Suppl 5): S94-104.
23. Mukhtyar C, Flossmann O, Hellmich B, Bacon P, Cid M, Cohen-Tervaert JW, et al, European Vasculitis Study Group (EUVAS). Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis a systematic review by the European League Against Rheumatism systemic vasculitis task force. Ann Rheum Dis 2008; 67: 1004-10.
24. Sanders JS, Stassen PM, van Rossum AP, Kallenberg CG, Stegeman CA. Risk factors for relapse in anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis: tools for treatment decisions? Clin Exp Rheumatol 2004; 22 (6 Suppl 36): S94-101.
25. Terrier B, Saadoun D, Sène D, Ghillani-Dalbin P, Amoura Z, Deray G, et al. Anti-myeloperoxidase antibodies are a useful marker of disease activity in ANCA-associated vasculitides. Ann Rheum Dis 2008 [Epub ahead of print].
26. Cattaneo L, Chierici E, Pavone L, Grasselli C, Manganelli P, Buzio C, et al. Peripheral neuropathy in Wegener's granulomatosis, Churg-Strauss syndrome and microscopic polyangiitis. J Neurol Neurosurg Psychiatry 2007; 78: 1119-23.